Literature DB >> 17163465

Prognostic value of plasminogen activator inhibitor-1 in head and neck squamous cell carcinoma.

Luciënne Speleman1, Jeroen D F Kerrebijn, Maxime P Look, Cees A Meeuwis, John A Foekens, Els M J J Berns.   

Abstract

BACKGROUND: Tumor cell biological factors, such as urokinase plasminogen activator (uPA) and its inhibitor plasminogen activator inhibitor-1 (PAI-1), cathepsin D, and c-myc play a role in tumor invasion, metastasis, and proliferation. In this study, the prognostic importance of these factors in patients with primary head and neck squamous cell carcinoma (HNSCC) was evaluated and correlated with clinicopathologic variables.
METHODS: In 46 paired primary tumors and normal tissues, levels of uPA, PAI-1, cathepsin D, and c-myc amplification were determined. The clinical follow-up was over 10 years. Relationships between cell biological factors and patient and tumor characteristics were studied by the Mann-Whitney test. The Cox proportional hazard model was used for univariate and multivariate analysis.
RESULTS: In this study, only a high level of PAI-1 was associated with a significantly shorter disease-free survival (p < .01). PAI-1 levels were higher in tumors with perineural invasion (p < .01). Both PAI-1 and uPA levels were higher in patients who smoked (p < .01 and p = .02). In univariate analysis, smoking (p= .04), excessive alcohol intake (p = .02), perineural invasion (p = .001), and vaso-invasion (p = .009) were associated with a shorter disease-free survival. The only factor related to overall survival was perineural invasion (p = .045). The combination of a high PAI-1 level and perineural invasion appeared to be a significant predictor of a shorter disease-free interval (p = .01).
CONCLUSION: PAI-1 may present a novel prognostic factor for patients with HNSCC. Perineural invasion and PAI-1 level combined seemed to be prognostic for disease-free survival. (c) 2006 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17163465     DOI: 10.1002/hed.20527

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  10 in total

1.  ARNTL2 and SERPINE1: potential biomarkers for tumor aggressiveness in colorectal cancer.

Authors:  Gianluigi Mazzoccoli; Valerio Pazienza; Anna Panza; Maria Rosa Valvano; Giorgia Benegiamo; Manlio Vinciguerra; Angelo Andriulli; Ada Piepoli
Journal:  J Cancer Res Clin Oncol       Date:  2011-12-24       Impact factor: 4.553

Review 2.  Impact of proteolytic enzymes in colorectal cancer development and progression.

Authors:  László Herszényi; Loránd Barabás; István Hritz; Gábor István; Zsolt Tulassay
Journal:  World J Gastroenterol       Date:  2014-10-07       Impact factor: 5.742

3.  Enhanced cell migration and apoptosis resistance may underlie the association between high SERPINE1 expression and poor outcome in head and neck carcinoma patients.

Authors:  Miguel Angel Pavón; Irene Arroyo-Solera; Marta Téllez-Gabriel; Xavier León; David Virós; Montserrat López; Alberto Gallardo; Maria Virtudes Céspedes; Isolda Casanova; Antonio López-Pousa; Maria Antonia Mangues; Miquel Quer; Agustí Barnadas; Ramón Mangues
Journal:  Oncotarget       Date:  2015-10-06

4.  Hypoxia induces TFE3 expression in head and neck squamous cell carcinoma.

Authors:  Zhi-Jun Sun; Guang-Tao Yu; Cong-Fa Huang; Lin-Lin Bu; Jian-Feng Liu; Si-Rui Ma; Wen-Feng Zhang; Bing Liu; Lu Zhang
Journal:  Oncotarget       Date:  2016-03-08

5.  Upregulation of Plasminogen Activator Inhibitor-1 in Irradiated Recipient Arteries and Veins from Free Tissue Transfer Reconstruction in Cancer Patients.

Authors:  Bjorn O Eriksson; Caroline Gahm; Martin Halle
Journal:  Mediators Inflamm       Date:  2018-10-04       Impact factor: 4.711

6.  Increased mortality in septic shock with the 4G/4G genotype of plasminogen activator inhibitor 1 in patients of white descent.

Authors:  Gloria García-Segarra; Gerard Espinosa; Dolors Tassies; Josep Oriola; Jesús Aibar; Albert Bové; Pedro Castro; Joan-Carles Reverter; Josep-Maria Nicolás
Journal:  Intensive Care Med       Date:  2007-05-31       Impact factor: 41.787

7.  Tumor marker utility and prognostic relevance of cathepsin B, cathepsin L, urokinase-type plasminogen activator, plasminogen activator inhibitor type-1, CEA and CA 19-9 in colorectal cancer.

Authors:  László Herszényi; Fabio Farinati; Romilda Cardin; Gábor István; László D Molnár; István Hritz; Massimo De Paoli; Mario Plebani; Zsolt Tulassay
Journal:  BMC Cancer       Date:  2008-07-10       Impact factor: 4.430

8.  Plasminogen activator inhibitor-1 enhances radioresistance and aggressiveness of non-small cell lung cancer cells.

Authors:  JiHoon Kang; Wanyeon Kim; TaeWoo Kwon; HyeSook Youn; Joong Sun Kim; BuHyun Youn
Journal:  Oncotarget       Date:  2016-04-26

Review 9.  uPA/uPAR and SERPINE1 in head and neck cancer: role in tumor resistance, metastasis, prognosis and therapy.

Authors:  Miguel Angel Pavón; Irene Arroyo-Solera; Maria Virtudes Céspedes; Isolda Casanova; Xavier León; Ramón Mangues
Journal:  Oncotarget       Date:  2016-08-30

10.  Development of a five-protein signature for predicting the prognosis of head and neck squamous cell carcinoma.

Authors:  Xinyuan Zhao; Xianwen Liu; Li Cui
Journal:  Aging (Albany NY)       Date:  2020-10-13       Impact factor: 5.682

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.